A promising strategy for overcoming MDR in tumor by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin

To overcome both the dose-limiting side effects of conventional chemotherapeutic agents and the therapeutic failure resulting from multidrug resistance (MDR) and minimize adverse effects of chemotherapy agents, a novel chemotherapy formulation of magnetic nanoparticles co-loaded with daunorubicin an...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Jian, Wang, Jun, Chen, Baoan, Xia, Guohua, Cai, Xiaohui, Liu, Ran, Ren, Yanyan, Bao, Wen, Wang, Xuemei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215153/
https://www.ncbi.nlm.nih.gov/pubmed/22114476
http://dx.doi.org/10.2147/IJN.S24309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215153/
https://www.ncbi.nlm.nih.gov/pubmed/22114476
http://dx.doi.org/10.2147/IJN.S24309

Ejemplares similares